Study to Compare Bictegravir/Lenacapavir Versus Current Therapy in People With HIV-1 Who Are Successfully Treated With a Complicated Regimen
Running, not enrolling · Phase 2/Phase 3
Conditions studied: HIV-1-infection
In brief
The goal of this clinical study is to learn more about the effects of switching to the study drugs, bictegravir (BIC) plus lenacapavir (LEN), versus current therapy (Phase 2) and BIC/LEN fixed-dose combination (FDC) versus current therapy (Phase 3) in people living with HIV (PWH).
Key facts
- Study ID
- NCT05502341
- Run by
- Gilead Sciences
- People needed
- 689
- Starts
- 2022-08-16
- Expected to finish
- 2028-07-01
- Last updated by the study team
- 2025-10-14
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Be Well Medical Center — Berkeley, California, United States
- Pacific Oaks Medical Group — Beverly Hills, California, United States
- Ruane Clinical Research Group, Inc — Los Angeles, California, United States
- Alta Bates Summit Medical Center, Summit Campus, East Bay Advanced Care — Oakland, California, United States
- Bios Clinical Research — Palm Springs, California, United States
- University of California San Diego (UCSD) — San Diego, California, United States
- Lundquist Institute for Biomedical Innovation at Harbor - UCLA Medical Center — Torrance, California, United States
- The Men's Health Foundation — West Hollywood, California, United States
- Denver Health Medical Center — Denver, Colorado, United States
- Yale University; School of Medicine; AIDS Program — New Haven, Connecticut, United States
- Midland Florida Clinical Research Center, LLC — DeLand, Florida, United States
- Therafirst Medical Centers — Fort Lauderdale, Florida, United States
- Gary Richmond, MD, PA, Inc. — Fort Lauderdale, Florida, United States
- Midway Immunology & Research Center, LLC — Ft. Pierce, Florida, United States
- Schiff Center for liver Diseases/University of Miami — Miami, Florida, United States
- Floridian Clinical Research — Miami Lakes, Florida, United States
- Orlando Immunology Center — Orlando, Florida, United States
- Therapeutic Concepts, PA — Orlando, Florida, United States
- Triple O Research Institute PA — West Palm Beach, Florida, United States
- Atlanta ID Group — Atlanta, Georgia, United States
- Mercer University School of Medicine — Macon, Georgia, United States
- Howard Brown Health Center — Chicago, Illinois, United States
- Kansas City Care Clinic — Kansas City, Missouri, United States
- Southampton Healthcare, Inc. — St Louis, Missouri, United States
- Hospital Clinico San Carlos — Madrid, Spain
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.